Upgrade to SI Premium - Free Trial

Innoviva (INVA)

20.84 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 4 Innoviva, Inc. For: Aug 20 Filed by: Zhen Marianne August 24, 2026 4:15 PM - SEC Filing Form 4 Innoviva, Inc. For: Aug 20 Filed by: Basso Stephen August 24, 2026 4:15 PM - SEC Filing Form 4 Innoviva, Inc. For: Aug 20 Filed by: Raifeld Pavel August 24, 2026 4:15 PM - SEC Filing Inova Technology (INVA) Reiterated at Overweight by Cantor Fitzgerald Post Webinar With CEO, CFO August 21, 2026 8:35 AM - StreetInsider Innoviva unit's three antibiotics named Prix Galien USA finalists August 11, 2026 4:06 PM - StreetInsider Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award August 11, 2026 4:05 PM - BizWire H.C. Wainwright Reiterates Buy Rating on Inova Technology, Inc. (INVA) August 10, 2026 6:45 AM - StreetInsider Innoviva (INVA) Misses Q2 EPS by 157c August 5, 2026 5:52 PM - StreetInsider Form 10-Q Innoviva, Inc. For: Jun 30 August 5, 2026 4:29 PM - SEC Filing Form 8-K Innoviva, Inc. For: Aug 05 August 5, 2026 4:25 PM - SEC Filing Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress August 5, 2026 4:05 PM - BizWire Form SCHEDULE 13G Innoviva, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:21 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Inova Technology, Inc. (INVA) June 22, 2026 7:04 AM - StreetInsider Nortiva Bio Launches to Develop Long-Acting Oral Medicines June 18, 2026 8:00 AM - BizWire Full Article List